Free Newsletter
Gates earmarks $100M for microbicide R&D
The Bill & Melinda Gates Foundation has put up $100 million to further advance promising microbicidal gels that can significantly reduce the spread of HIV. The money was committed after the Maryland-based International Partnership for Microbicides, or IPM, reported positive results for a clinical trial involving a new gel.
There is no effective microbicide in use, but the IPM is convinced that a new product could save millions of lives. A gel would be particularly effective in developing countries where men are often reluctant to use a condom. And in January researchers for the NIH announced that the gel PRO2000 was 30 percent more effective than other products in preventing the spread of the virus in a mid-stage trial.
"IPM will bring pioneering HIV prevention technologies into 10 new clinical studies this year," said the IPM in a statement, including long-acting vaginal gels and vaginal rings that could provide sustained protection for up to a month."
- check out the report from the AFP
Related Articles:
Indevus HIV gel misses Phase III endpoint
Gates gives $168M for research into malaria vax
Has the Gates Foundation created a malaria 'cartel'?
Comments
Post new comment
Paid Research Reports
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Pharmaceutical Licensing Overview
- Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
- Pharmaceutical Key Trends 2010
- Commercial Insight: Top 20 Oncology Therapy Brands in Australia
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities

SHARE
WITH: